Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Lantheus
LNTH
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Teradata Corp
TDC
(Q3)Sep 30, 2023 | (Q3)Sep 30, 2022 | (Q3)Sep 30, 2018 | (Q2)Jun 30, 2018 | (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -2.88%4.78M | 4.92M | 116.20%16.83M | 159.53%14.8M | 191.61%10.54M | 231.37%26.52M | 269.00%9.42M | 255.62%7.78M | 230.46%5.7M | 135.25%3.61M |
Operating revenue | -2.88%4.78M | --4.92M | 116.20%16.83M | 159.53%14.8M | 191.61%10.54M | 231.37%26.52M | 269.00%9.42M | 255.62%7.78M | 230.46%5.7M | 135.25%3.61M |
Cost of revenue | 8.89%957.74K | 879.57K | 73.52%4.77M | 288.22%6.24M | 199.26%3.19M | 141.04%8.11M | 129.91%2.69M | 198.08%2.75M | 187.75%1.61M | 49.24%1.07M |
Gross profit | -5.44%3.82M | 4.04M | 139.50%12.06M | 109.03%8.56M | 188.40%7.34M | 296.93%18.41M | 386.61%6.73M | 297.51%5.03M | 250.90%4.1M | 210.23%2.55M |
Operating expense | -12.00%3.74M | 4.24M | 69.35%11.46M | 119.90%10.57M | 145.58%8.69M | 156.10%23.15M | 158.94%8.04M | 181.16%6.77M | 108.66%4.81M | 188.86%3.54M |
Selling and administrative expenses | -12.00%3.74M | --4.24M | 73.13%11.46M | 126.88%10.57M | 156.56%8.69M | 96.99%16.69M | -31.39%2.03M | 194.42%6.62M | 117.98%4.66M | 199.19%3.39M |
-Selling and marketing expense | -10.89%1.32M | --1.48M | 3,769.86%7.44M | 1,501.83%7.15M | 2,899.48%6.22M | 148.44%1.61M | 156.86%759.14K | 6.30%192.27K | 265.74%446.6K | 334.83%207.53K |
-General and administrative expense | -12.59%2.42M | --2.76M | -37.50%4.02M | -18.95%3.41M | -22.45%2.47M | 92.74%15.08M | -52.30%1.27M | 210.88%6.43M | 109.03%4.21M | 193.22%3.18M |
Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | -12.48%494.27K | -67.92%47.13K | -6.81%147.78K | -11.11%147.78K | 63.01%151.58K |
-Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -12.48%494.27K | -67.92%47.13K | -6.81%147.78K | -11.11%147.78K | 63.01%151.58K |
Other operating expenses | ---- | ---- | ---- | ---- | ---- | --5.96M | ---- | ---- | ---- | ---- |
Operating profit | 140.05%82.86K | -206.91K | 134.74%601.18K | -182.67%-2.01M | -35.90%-1.35M | -7.64%-4.74M | 24.27%-1.3M | -51.85%-1.73M | 37.53%-709.43K | -145.54%-993.76K |
Net non-operating interest income expense | -31.31%32.44K | 47.22K | 78.77%-260.77K | 85.54%-193.18K | 66.76%-380.3K | 43.77%-6.25M | 43.70%-2.54M | 57.60%-1.23M | 55.23%-1.34M | -58.83%-1.14M |
Non-operating interest income | 4.25%67.55K | --64.79K | -48.84%39.11K | -88.41%38.15K | 1,129.41%77.24K | 34,174.77%771.53K | 643.60%359.58K | 236.07%76.44K | 621.15%329.23K | --6.28K |
Non-operating interest expense | 99.86%35.11K | --17.57K | -77.02%299.88K | -86.11%231.33K | -60.22%457.55K | -36.84%7.02M | -34.77%2.9M | -55.31%1.31M | -45.03%1.66M | 59.70%1.15M |
Other net income (expense) | 52.50%-964.42K | -2.03M | -22.72M | -18.87M | -156,208.18%-132.86M | -1,109.81%-131.22M | 99.15%-85K | |||
Gain on sale of security | 85.11%-272.87K | ---1.83M | ---22.71M | ---18.7M | ---132.5M | ---- | ---- | ---- | ---- | ---- |
Special income (charges) | ---- | ---- | --0 | ---143.87K | -323.05%-359.59K | -14,004.35%-131.22M | ---- | ---- | --0 | -5,444.68%-85K |
-Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | --130.84M | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---11.41K | 270.15%314.63K | -90.70%85K | ---- | ---- | ---- | --85K |
-Write off | ---- | ---- | --0 | --155.28K | --44.97K | 1,703.48%288.77K | ---- | ---- | --0 | ---- |
Other non- operating income (expenses) | -249.86%-691.55K | ---197.67K | ---7.46K | ---24.7K | ---1.47K | ---- | ---- | ---- | ---- | ---- |
Income before tax | 61.23%-849.12K | -2.19M | -656.28%-22.38M | -930.35%-21.07M | -5,955.05%-134.59M | -439.52%-142.2M | -1,902.71%-134.97M | 34.36%-2.96M | 48.80%-2.05M | 80.00%-2.22M |
Income tax | ||||||||||
Net income | 61.23%-849.12K | -2.19M | -656.28%-22.38M | -930.35%-21.07M | -5,955.05%-134.59M | -461.93%-148.1M | -1,990.35%-140.88M | 34.36%-2.96M | 48.80%-2.05M | 80.00%-2.22M |
Net income continuous Operations | 61.23%-849.12K | ---2.19M | -656.28%-22.38M | -930.35%-21.07M | -5,955.05%-134.59M | -439.52%-142.2M | -1,902.71%-134.97M | 34.36%-2.96M | 48.80%-2.05M | 80.00%-2.22M |
Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | ---5.91M | ---- | ---- | ---- | ---- |
Minority interest income | 0 | 0 | ||||||||
Net income attributable to the parent company | 61.23%-849.12K | -2.19M | -656.28%-22.38M | -930.35%-21.07M | -5,955.05%-134.59M | -471.65%-148.1M | -2,060.84%-140.88M | 30.97%-2.96M | 48.94%-2.05M | 79.97%-2.22M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 61.23%-849.12K | -2.19M | -656.28%-22.38M | -930.35%-21.07M | -5,955.05%-134.59M | -471.65%-148.1M | -2,060.84%-140.88M | 30.97%-2.96M | 48.94%-2.05M | 79.97%-2.22M |
Basic earnings per share | 63.14%-0.0002 | -0.0005 | -599.78%-0.0065 | -851.48%-0.0061 | -5,523.86%-0.0396 | -446.24%-0.0453 | -1,964.86%-0.0431 | 34.86%-0.0009 | 52.69%-0.0006 | 81.80%-0.0007 |
Diluted earnings per share | 63.14%-0.0002 | -0.0005 | -599.78%-0.0065 | -851.48%-0.0061 | -5,523.86%-0.0396 | -446.24%-0.0453 | -1,964.86%-0.0431 | 34.86%-0.0009 | 52.69%-0.0006 | 81.80%-0.0007 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |